Recently, functional assays exhibited that high miR-150 expression suppressed the proliferative potential and clonogenic growth, increased chemosensitivity, and ameliorated in vitro tumorigenicity of CD34+/CD38− AML-LSCs. The gene discussed is CD34; the disease is acute myeloid leukemia.